Tuesday, January 03, 2006 10:51:38 AM
who cares about safety Increlex is easier to store
It can be put in the refrigerator instead of the freezer, oh my.
I'm sure the kids getting 2 shots instead of one and the parents giving the shots are worried about the part of the refrigerator they have to place the drug.
With today's commercial launch of Increlex, physicians can now prescribe a safe and effective drug backed by 321 patient-years of clinical trial treatment experience in children affected by severe Primary IGFD," said John A. Scarlett, M.D., President and Chief Executive Officer of Tercica. "In addition to a label with safety and efficacy data representing up to 12.5 years of treatment in some children, Increlex is the most convenient rhIGF-1 replacement therapy product for parents and children to store, transport and administer." Increlex was generally well tolerated and no subjects withdrew from the clinical trials due to adverse events. The most common drug-related adverse events were hypoglycemia, lipohypertrophy, and tonsillar hypertrophy.
It can be put in the refrigerator instead of the freezer, oh my.
I'm sure the kids getting 2 shots instead of one and the parents giving the shots are worried about the part of the refrigerator they have to place the drug.
With today's commercial launch of Increlex, physicians can now prescribe a safe and effective drug backed by 321 patient-years of clinical trial treatment experience in children affected by severe Primary IGFD," said John A. Scarlett, M.D., President and Chief Executive Officer of Tercica. "In addition to a label with safety and efficacy data representing up to 12.5 years of treatment in some children, Increlex is the most convenient rhIGF-1 replacement therapy product for parents and children to store, transport and administer." Increlex was generally well tolerated and no subjects withdrew from the clinical trials due to adverse events. The most common drug-related adverse events were hypoglycemia, lipohypertrophy, and tonsillar hypertrophy.
Recent INSM News
- Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference • PR Newswire (US) • 05/27/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2026 08:55:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:25:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:06:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/18/2026 08:53:52 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/15/2026 09:02:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:08:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:06:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:01:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 09:20:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:24:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:18:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:17:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:17:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:14:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:50:00 PM
